Orally administered clonidine, insulin-induced hypoglycemia, and exercise are widely used hGH stimulation tests (6) (7) (8) . Clonidine is a central alpha-2-adrenergic stimulatory agent which activates the hypothalamo-hypophyseal axis and inhibits ACTH and cortisol secretion (9); hypoglycemia is a stress¬ ful stimulus which activates the hypothalamo-hypophyseal-adrenal axis and the secretion of ACTH and cortisol, and acute exercise is a physiological stimulus which induces release of the stress hor¬ mones resembling the situation during hypoglyce¬ mia. Recent studies in the rat provide evidence that clonidine induces GH secretion by activation of hypothalamic GHRH (10, 11) . On the other hand, there are conflicting results regarding the mecha¬ nism by which insulin hypoglycemia stimulates hGH secretion (12) (13) (14) .
growth hormone releasing hormone from various tissues (1, 2) and the development of sensitive me¬ thods for its determination in plasma and hypo¬ thalamus (3) (4) (5) have made it possible to study the mechanisms by which neuroactive drugs affect growth hormone secretion.
Orally administered clonidine, insulin-induced hypoglycemia, and exercise are widely used hGH stimulation tests (6) (7) (8) . Clonidine is a central alpha-2-adrenergic stimulatory agent which activates the hypothalamo-hypophyseal axis and inhibits ACTH and cortisol secretion (9) ; hypoglycemia is a stress¬ ful stimulus which activates the hypothalamo-hypophyseal-adrenal axis and the secretion of ACTH and cortisol, and acute exercise is a physiological stimulus which induces release of the stress hor¬ mones resembling the situation during hypoglyce¬ mia. Recent studies in the rat provide evidence that clonidine induces GH secretion by activation of hypothalamic GHRH (10, 11) . On the other hand, there are conflicting results regarding the mecha¬ nism by which insulin hypoglycemia stimulates hGH secretion (12) (13) (14) .
It was the aim of this study to elucidate the mech¬ anism by which these stimuli act to release hGH by measuring their concomitant effect on hGH and GHRH in plasma.
Subjects and Materials
The entire study population comprised 55 healthy shortstature children and adolescents (31 males, 24 females), aged 7-16 years. Height standard deviation score range was from -2 to -4.5 SD. In all the children hGH defi¬ ciency could be ruled out by hGH peak values of >0.37 nmol/1. All the procedures were performed within the frame of developmental evaluation. Explanation was given to parents and children and informed consent was obtained. The study was approved by the hospital's Eth¬ ical Committee. Thirty-one subjects (24 males, 7 to a peak of 12.27 ± 2.5 pmol/1 at 60 min (p<0.01).Neither hypoglycemia nor exercise in¬ duced a significant rise in plasma GHRH levels ( Fig. 1 and 2) Studies in animals also provide evidence that clo¬ nidine induces GH secretion by stimulating hypothalamic GHRH release: passive immunization of rats with antiserum to GHRH inhibited the clonidine-induced secretion of GH (17) . Long-term treatment with clonidine caused a depletion in hypothalmic GHRH content in the rat (18) , and in¬ cubation of clonidine with rat hypothalami en¬ hanced the secretion of GHRH (10) . Although the above reports strongly suggest a stimulatory role of clonidine on hypothalamic GHRH release, there is no direct evidence regarding its mechanism in man. At variance with our study, Rosskamp & Haverkamp (19) reported no change in plasma GHRH levels following clonidine in short-stature (26, 27) . It has been suggested that .beta-endorphin and the opiatergic system play a role in the regulation of GH secretion (28) , and studies in the rat provided ev¬ idence that the alpha-adrenergic and the opiatergic system stimulate GH secretion through activation of GHRH (11) . In man, however, pre-treatment with naloxone did not affect the hGH response to exercise, suggesting that the opioid pathway is not involved in this response (29) .
The findings of the present study support the concept that clonidine stimulates hGH secretion by an enhancement of GHRH release, whereas stress stimuli achieve this through a different mecha¬ nism, possibly by inhibition of somatostatin.
